Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
Book of Abstracts - Ruhr-Universität Bochum
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
P-73<br />
ISBOMC `10 5.7 – 9.7. 2010 <strong>Ruhr</strong>-<strong>Universität</strong> <strong>Bochum</strong><br />
Asborin Meets Titanium<br />
Matthias Scholz a and Evamarie Hey-Hawkins* a<br />
a <strong>Universität</strong> Leipzig, Institute <strong>of</strong> Inorganic Chemistry, Johannisallee 29, D-04103 Leipzig, Germany,<br />
E-mail: mscholz@chemie.uni-leipzig.de<br />
Asborin, the carbaborane analogue <strong>of</strong> aspirin ® , is one <strong>of</strong> the few examples in which carbaboranes are<br />
used as phenyl-mimetic pharmacophores. Asborin was synthesised in a high-yield procedure starting<br />
from ortho-carbaborane. The compound proved to inhibit both cyclooxygenase (COX) isozymes, the<br />
target enzymes <strong>of</strong> aspirin. 1 The COX inhibition potential, however, was lower compared to aspirin and<br />
the general pharmacological pr<strong>of</strong>ile was also different to that <strong>of</strong> aspirin. Integration <strong>of</strong> the cluster in<br />
place <strong>of</strong> the phenyl ring turned aspirin into a more toxic compound, which triggers apoptosis<br />
pathways. Asborin was cytotoxic toward several cancer cell lines and exhibited the lowest potency<br />
toward healthy fibroblasts. This behaviour made the carbaborane compound interesting for anticancer<br />
drug development. As the IC50 values obtained from the cytotoxicity assays were higher than those <strong>of</strong><br />
commercial chemotherapeutic agents, the compound requires further fine-tuning <strong>of</strong> its cytotoxic<br />
pr<strong>of</strong>ile.<br />
A promising approach to increase the antitumour activity <strong>of</strong> asborin is combination with another<br />
cytotoxic moiety. Therefore, we decided to modify asborin with titanium complexes, as some<br />
derivatives were found to be active toward several tumour cells. The most prominent anticancer<br />
titanium derivatives are the organometallic compound titanocene dichloride and the bioinorganic<br />
complex budotitane. 2 The carboxyl group and carbaborane moiety <strong>of</strong> asborin allow it to form both<br />
bioinorganic and organometallic titanium compounds. Coordination <strong>of</strong> asborin as carboxylate could<br />
displace the chloride ions in titanocene dichloride. Alternatively, instead <strong>of</strong> a cyclopentadienyl ring the<br />
nido carbaborane cluster can act as ligand for titanium. Thus, carbaboranes can easily be deboronated<br />
to give anionic nido clusters, which feature an open pentagonal plane. These anions can then form<br />
different metallocene analogues.<br />
References<br />
1. M. Scholz, K. Bensdorf, R. Gust, E. Hey-Hawkins, ChemMedChem. 2009, 4, 746-748.<br />
2. J. C. Dabrowiak: Titanium compounds for treating cancer in Metals in Medicine; 1. Ed.; Wiley:<br />
New York, USA, 2009; pp. 167-177.<br />
131